Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.

MLA

Treon, Steven P., et al. “Somatic Mutations in MYD88 and CXCR4 Are Determinants of Clinical Presentation and Overall Survival in Waldenstrom Macroglobulinemia.” Blood, vol. 123, no. 18, May 2014, pp. 2791–96. EBSCOhost, https://doi.org/10.1182/blood-2014-01-550905.

APA

Treon, S. P., Cao, Y., Xu, L., Yang, G., Liu, X., & Hunter, Z. R. (2014). Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood, 123(18), 2791–2796. https://doi.org/10.1182/blood-2014-01-550905

Chicago

Treon, Steven P, Yang Cao, Lian Xu, Guang Yang, Xia Liu, and Zachary R Hunter. 2014. “Somatic Mutations in MYD88 and CXCR4 Are Determinants of Clinical Presentation and Overall Survival in Waldenstrom Macroglobulinemia.” Blood 123 (18): 2791–96. doi:10.1182/blood-2014-01-550905.